• Refine your search:
  • 
    Keyword
  • 
    Creator / Publisher:
    
    • Agassis, S. (1)
    • Baur, A.S. (1)
    • Frossard, V. (1)
    • George, A.C. (1)
    • Janzer, R. (1)
    • Ketterer, N. (1)
    • Leyvraz, S. (1)
    • Meuli, R. (1)
    • Ozsahin, M. (1)
  • 
    Year:
    
    • 2005 (1)
  • 
    Medium
  • 
    Type
  • 
    BLLDB-Access

Search in the Catalogues and Directories

All fields Title Creator / Publisher Keyword Year AND OR AND NOT All fields Title Creator / Publisher Keyword Year AND OR AND NOT All fields Title Creator / Publisher Keyword Year AND OR AND NOT All fields Title Creator / Publisher Keyword Year AND OR AND NOT All fields Title Creator / Publisher Keyword Year Sort by creator [A → Z]' creator [Z → A]' publishing year ↑ (asc)' publishing year ↓ (desc)' title [A → Z]' title [Z → A]' Simple Search Hits 1 – 1 of 1 1 Primary intracranial dural lymphoma of mucosa-associated lymphoid tissue (MALT) type: report of one case and review of the literature. George, A.C.; Ozsahin, M.; Janzer, R.; Agassis, S.; Meuli, R.; Baur, A.S.; Frossard, V.; Leyvraz, S.; Ketterer, N. In: Bulletin du Cancer, vol. 92, no. 7, pp. E51-E56 (2005) Abstract: Primary indolent leptomeningeal lymphoma is a rare entity, and corresponds in most cases to mucosa-associated lymphoid tissue (MALT) type lymphoma. We are reporting a case of a 75 years old woman, who presented with a 2-year history of behavioral disorder, progressive memory loss and aphasia. Neuroimaging showed a mass infiltrating the frontal circumvolutions and the roof of the orbit. The biopsy revealed an infiltration of the dura by an indolent lymphoma, characteristic of a MALT-type lymphoma. Complete staging work-up did not show any evidence of systemic involvement. A treatment with systemic methotrexate, combined with intrathecal chemotherapy and followed by radiotherapy (30,6 Gy) of the primary site, was conducted. The 3-year follow-up confirms the persistent remission, the patient remaining well and free of symptoms. The review of the literature highlights the importance to recognize the indolent PLML as a distinct clinical entity, which exhibits a rather good prognosis following a relatively non-toxic therapy. Keyword: Aged; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; B-Cell; Combined Modality Therapy; Cytarabine/administration & dosage; Dura Mater; Female; Humans; Hydrocortisone/administration & dosage; Lymphoma; Marginal Zone/cerebrospinal fluid; Marginal Zone/pathology; Meningeal Neoplasms/cerebrospinal fluid; Meningeal Neoplasms/pathology; Methotrexate/administration & dosage URL: https://serval.unil.ch/notice/serval:BIB_D234D3407DDA BASE Hide details

Mobile view All Catalogues UB Frankfurt Linguistik 0 IDS Mannheim 0 OLC Linguistik 0 UB Frankfurt Retrokatalog 0 DNB Subject Category Language 0 Institut für Empirische Sprachwissenschaft 0 Leibniz-Centre General Linguistics (ZAS) 0 Bibliographies BLLDB 0 BDSL 0 IDS Bibliografie zur deutschen Grammatik 0 IDS Bibliografie zur Gesprächsforschung 0 IDS Konnektoren im Deutschen 0 IDS Präpositionen im Deutschen 0 IDS OBELEX meta 0 MPI-SHH Linguistics Collection 0 MPI for Psycholinguistics 0 Linked Open Data catalogues Annohub 0 Online resources Link directory 0 Journal directory 0 Database directory 0 Dictionary directory 0 Open access documents BASE 1 Linguistik-Repository 0 IDS Publikationsserver 0 Online dissertations 0 Language Description Heritage 0